EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Device therapies for heart failure with reduced ejection fraction: a new era

Rohit Mody, Abha Bajaj Nee Sheth, Debabrata Dash, Bhavya Mody, Ankit Agrawal, Inderjeet Singh Monga, Lakshay Rastogi, Amit Munjal

Frontiers in Cardiovascular Medicine · 18.10.2024 · 11

DOI: 10.3389/fcvm.2024.1388232 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 18.10.2024. Verfasst von Rohit Mody und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Mody Harvard Cardiac Institute & Research Centre, Krishna Super Specialty Hospital, Bathinda, India. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Even with significant advancements in the treatment modalities for patients with heart failure (HF), the rates of morbidity and mortality associated with HF are still high. Various therapeutic interventions, including cardiac resynchronization therapy, Implantable Cardiovascular-Defibrillators, and left ventricular assist devices, are used for HF management. Currently, more research and developments are required to identify different treatment modalities to reduce hospitalization rates and improve the quality of life of patients with HF. In relation to this, various non-valvular catheter-based therapies have been recently developed for managing chronic HF. These devices target the pathophysiological processes involved in HF development including neurohumoral activation, congestion, and left ventricular remodeling. The present review article aimed to discuss the major transcatheter devices used in managing chronic HF. The rationale and current clinical developmental stages of these interventions will also be addressed in this review.

Schlagwörter

Stichwörter der Autor:innen

cardiac resynchronizationcongestive heart failuredeviceimplantable cathetersminimally invasive surgery

Autor:innen und Institutionen

  • Department of Cardiology, Mody Harvard Cardiac Institute & Research Centre, Krishna Super Specialty Hospital, Bathinda, India.
  • Department of Anatomy, Dr Harvansh Singh Judge Institute of Dental Sciences & Hospital, Panjab University, Chandigarh, India.
  • Department of Cardiology, Aster Hospital, Dubai, United Arab Emirates.
  • Department of Medicine, Kasturba Medical College, Manipal, India.
  • Department of Cardiology, Cleveland Clinic, Cleveland, OH, United States.
  • Department of Cardiology, Command Hospital Chandimandir, Panchkula, India.

Zitieren

APA

Mody, R., Nee Sheth, A. B., Dash, D., Mody, B., Agrawal, A., Monga, I. S., Rastogi, L., & Munjal, A. (2024). Device therapies for heart failure with reduced ejection fraction: a new era. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1388232

Vancouver

Mody R, Nee Sheth AB, Dash D, Mody B, Agrawal A, Monga IS, et al. Device therapies for heart failure with reduced ejection fraction: a new era. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1388232

BibTeX
@article{Mody2024,
  author = {Mody, Rohit and Nee Sheth, Abha Bajaj and Dash, Debabrata and Mody, Bhavya and Agrawal, Ankit and Monga, Inderjeet Singh and Rastogi, Lakshay and Munjal, Amit},
  title = {Device therapies for heart failure with reduced ejection fraction: a new era},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fcvm.2024.1388232}
}
Kostenlos starten →